跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 617 条关于
“SpeechDx”
全部
617
临床试验
598
药物
0
机构
3
资讯
16
11个月前
ADDF Releases SpeechDx Dataset to Advance AI-Powered Alzheimer's Detection Through Speech Biomarkers
去年
Alzheimer's Drug Discovery Foundation Partners with Siemens Healthineers to License SpeechDx Dataset for Speech-Based Biomarker Development
去年
Reviva Presents Positive Brilaroxazine Data on Speech Latency in Schizophrenia from Phase 3 RECOVER Trial
3个月前
AI-Powered Speech Assessment Detects Alzheimer's Pathology Through Automated Phone Calls
去年
Brooks Rehabilitation and Universities Partner to Advance Motor Speech Disorder Treatment
去年
Reviva Presents Positive Speech Latency Data for Brilaroxazine in Schizophrenia from Phase 3 RECOVER Trial
去年
Brain Implant Breakthrough Enables Real-Time Speech for Stroke Survivor After 18 Years
去年
Brain-Computer Interface Advances Enable Speech Synthesis and Action Control in Epilepsy Patient
去年
Reviva Pharma's Brilaroxazine Shows Positive Speech Latency Data in Phase 3 Schizophrenia Trial
去年
C7 Neurotomy Combined with Speech Therapy Shows Superior Results for Chronic Post-Stroke Aphasia
第 1 页,共 2 页
上一页
下一页